The company says the Nellcor system is designed to provide continuous monitoring of blood oxygenation, pulse rate and trend data. It will be available in the United States and throughout the EEA in the next few months.
“We are pleased to announce clearance to market the Nellcor Bedside Respiratory Patient Monitoring system in the United States and the European Economic Area,” said Robert J. White, president, respiratory and monitoring solutions, for Covidien. “With this addition, we now offer an updated portfolio of industry-leading bedside monitoring solutions that meet unique care needs in both high- and low-acuity settings, thus enhancing patient safety in hospitals throughout the world.”
Features of the new system include a color touch-screen graphical user interface and a variety of wired and wireless connectivity options.
Covidien has its U.S. headquarters in Mansfield, Mass.
Related Articles on FDA Clearances:
Echometrix Receives FDA Clearance for EchoSoft Ultrasound Technology
VBOX Receives FDA Clearance for Portable Oxygen Concentrator
Amedica Receives FDA Clearance for Interbody Fusion Device System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
